Skip to content

Author

A. Kropiwnicka

We have 5 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review

Innovative Technologies in Social

A. Żurakowska-Zadrożna, Aleksander Kacper Kierys, Klaudia Karolina et al. · 0 citations
Review Open access Sep 2026

SCREEN TIME AND SLEEP DISTURBANCES IN ADOLESCENTS: A NARRATIVE REVIEW

Sleep disturbances are common among adolescents and represent an important public health concern due to their effects on physical health, emotional regulation, cognitive functioning, and daytime performance. At the same time, screen-based behaviors have become a central component of adolescent life, raising concerns ab...

Krzysztof Sebastian Habirek, M. Porażko, A. Żurakowska-Zadrożna et al. · 0 citations
Review Open access Sep 2026

THE CLINICAL SPECTRUM OF EXCESSIVE SLEEPINESS: NEUROBIOLOGICAL MECHANISMS, ASSESSMENT, AND TREATMENT- A NARRATIVE REVIEW

Hypersomnolence disorders constitute a heterogeneous group of conditions characterized by excessive daytime sleepiness (EDS), impaired alertness, and reduced quality of life. These disorders represent a significant medical and social challenge due to their impact on cognitive functioning, occupational performance, inte...

Z. Marcinkowska, Krzysztof Sebastian Habirek, M. Porażko et al. · 0 citations
Review Open access Aug 2026

Long COVID and Mental Health: Neurobiological Mechanisms, Clinical Manifestations, and Treatment Challenges

Background: Long COVID is a heterogeneous multisystem condition associated with fatigue, cognitive difficulties, sleep disturbance, depression, anxiety, and post-traumatic symptoms. Methods: This narrative review examined PubMed/MEDLINE literature published between January 2020 and July 2026, supplemented by major rev...

Sandra Kołodziejczyk, Bartłomiej Wiak, Monika Łapot et al. · 0 citations
Review Open access Aug 2026

Neuroinflammation in Major Depressive Disorder: Mechanisms, Biomarkers, and Therapeutic Implications

Inflammation contributes to MDD in some patients, but single-marker diagnosis and routine anti-inflammatory treatment are not currently justified, and biomarker-stratified trials are needed to develop precision therapies.

Emilia Włoszek, Bartosz Mikołajek, Anita Godlewska et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.